vs

Side-by-side financial comparison of MONARCH CASINO & RESORT INC (MCRI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

MONARCH CASINO & RESORT INC is the larger business by last-quarter revenue ($136.6M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 8.9%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 3.2%).

The Atlantis Casino Resort Spa is a hotel and casino located in Reno, Nevada, United States. It is owned and operated by Monarch Casino & Resort, Inc. Its three hotel towers have a combined 824 guest rooms and suites. The casino floor spans 64,814 sq ft. Often known simply as "Atlantis," it is one of Reno's most profitable and luxurious properties, competing directly with Peppermill Hotel Casino and Grand Sierra Resort for customers. Nearly $150 million has been spent on upgrading the facility.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

MCRI vs PBYI — Head-to-Head

Bigger by revenue
MCRI
MCRI
1.8× larger
MCRI
$136.6M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+18.8% gap
PBYI
27.7%
8.9%
MCRI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
3.2%
MCRI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MCRI
MCRI
PBYI
PBYI
Revenue
$136.6M
$75.5M
Net Profit
$27.6M
Gross Margin
69.3%
Operating Margin
25.6%
22.7%
Net Margin
20.2%
Revenue YoY
8.9%
27.7%
Net Profit YoY
38.9%
EPS (diluted)
$1.52
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCRI
MCRI
PBYI
PBYI
Q1 26
$136.6M
Q4 25
$140.0M
$75.5M
Q3 25
$142.8M
$54.5M
Q2 25
$136.9M
$52.4M
Q1 25
$125.4M
$46.0M
Q4 24
$134.5M
$59.1M
Q3 24
$137.9M
$80.5M
Q2 24
$128.1M
$47.1M
Net Profit
MCRI
MCRI
PBYI
PBYI
Q1 26
$27.6M
Q4 25
$22.9M
Q3 25
$31.6M
$8.8M
Q2 25
$27.0M
$5.9M
Q1 25
$19.9M
$3.0M
Q4 24
$4.2M
Q3 24
$27.6M
$20.3M
Q2 24
$22.7M
$-4.5M
Gross Margin
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
20.8%
69.3%
Q3 25
26.7%
77.7%
Q2 25
25.5%
76.5%
Q1 25
20.2%
77.1%
Q4 24
2.9%
76.4%
Q3 24
25.6%
63.9%
Q2 24
23.0%
77.4%
Operating Margin
MCRI
MCRI
PBYI
PBYI
Q1 26
25.6%
Q4 25
21.3%
22.7%
Q3 25
27.1%
17.6%
Q2 25
25.8%
12.7%
Q1 25
20.4%
8.7%
Q4 24
3.1%
22.6%
Q3 24
25.5%
27.4%
Q2 24
22.9%
-4.6%
Net Margin
MCRI
MCRI
PBYI
PBYI
Q1 26
20.2%
Q4 25
16.4%
Q3 25
22.1%
16.2%
Q2 25
19.7%
11.2%
Q1 25
15.8%
6.5%
Q4 24
3.1%
Q3 24
20.0%
25.2%
Q2 24
17.7%
-9.6%
EPS (diluted)
MCRI
MCRI
PBYI
PBYI
Q1 26
$1.52
Q4 25
$1.25
$0.26
Q3 25
$1.69
$0.17
Q2 25
$1.44
$0.12
Q1 25
$1.05
$0.06
Q4 24
$0.25
$0.40
Q3 24
$1.47
$0.41
Q2 24
$1.19
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCRI
MCRI
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$120.1M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$549.8M
$130.3M
Total Assets
$725.2M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCRI
MCRI
PBYI
PBYI
Q1 26
$120.1M
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Total Debt
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Stockholders' Equity
MCRI
MCRI
PBYI
PBYI
Q1 26
$549.8M
Q4 25
$537.7M
$130.3M
Q3 25
$558.4M
$115.3M
Q2 25
$539.2M
$104.7M
Q1 25
$535.6M
$97.1M
Q4 24
$517.7M
$92.1M
Q3 24
$513.3M
$71.1M
Q2 24
$498.4M
$48.5M
Total Assets
MCRI
MCRI
PBYI
PBYI
Q1 26
$725.2M
Q4 25
$712.8M
$216.3M
Q3 25
$725.4M
$202.9M
Q2 25
$705.8M
$194.9M
Q1 25
$712.1M
$196.2M
Q4 24
$691.6M
$213.3M
Q3 24
$671.1M
$220.7M
Q2 24
$672.4M
$205.0M
Debt / Equity
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCRI
MCRI
PBYI
PBYI
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
$38.1M
$14.4M
Q3 25
$56.0M
$9.7M
Q2 25
$34.1M
$14.1M
Q1 25
$36.5M
$3.6M
Q4 24
$37.8M
$15.6M
Q3 24
$40.3M
$11.0M
Q2 24
$24.3M
$1.0M
Free Cash Flow
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
$32.2M
$14.4M
Q3 25
$53.5M
$9.7M
Q2 25
$26.0M
$14.1M
Q1 25
$16.6M
$3.6M
Q4 24
$26.2M
$15.6M
Q3 24
$35.4M
$11.0M
Q2 24
$11.0M
$1.0M
FCF Margin
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
23.0%
19.1%
Q3 25
37.5%
17.7%
Q2 25
19.0%
26.8%
Q1 25
13.3%
7.7%
Q4 24
19.5%
26.4%
Q3 24
25.7%
13.7%
Q2 24
8.5%
2.1%
Capex Intensity
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
4.2%
0.0%
Q3 25
1.7%
0.0%
Q2 25
5.9%
0.0%
Q1 25
15.8%
0.1%
Q4 24
8.6%
0.0%
Q3 24
3.6%
0.0%
Q2 24
10.4%
0.0%
Cash Conversion
MCRI
MCRI
PBYI
PBYI
Q1 26
Q4 25
1.66×
Q3 25
1.77×
1.10×
Q2 25
1.26×
2.41×
Q1 25
1.84×
1.21×
Q4 24
8.98×
Q3 24
1.46×
0.54×
Q2 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCRI
MCRI

Casino$79.7M58%
Food and beverage$31.7M23%
Hotel$19.0M14%
Other$6.1M5%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons